September 21, 2020

“The event was an extremely well-organized opportunity…
Thanks to its digital nature, I could join from Switzerland, a very nice side effect from COVID-19.”
Recent Xcelerating Life Sciences Attendee


10:30am ET

Discuss, Deploy, or Defer: New Technologies in Real World Biopharmaceutical Manufacturing

Jeff Baker – Deputy Director, Office of Biotechnology Products, FDA

11:05am ET

Building Out a Novel RNAi Pipeline in an Accelerated Timeline: From Rare Disease to COVID-19

John Maraganore – CEO, Alnylam Pharmaceuticals

11:45am ET


Utilize our networking app to view the entire attendee list, request and schedule meetings, host presentation materials and content assets, watch the full recording post-event, and access prior, during, and 60 days after the event. Learn more.

1:00pm ET

Panel Discussion: Accelerating R&D During a Pandemic – An Unprecedented Collaboration

Featuring senior-level representatives from Alnylam, Amgen, Takeda & UCB

2:00pm ET

Fireside Chat with Michelle McMurry-Heath – President & CEO of BIO